Filtered By:
Source: Medscape Today Headlines
Drug: Metformin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Metformin Superior to Glipizide in Diabetics With CADMetformin Superior to Glipizide in Diabetics With CAD
Over a median follow-up of five years, treatment with metformin reduced the primary composite end point of death from cardiovascular causes, death from any cause, nonfatal MI, nonfatal stroke, and arterial revascularization by 46% compared with glipizide. Heartwire
Source: Medscape Today Headlines - January 3, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news
